# Inovio Pharmaceuticals, Inc.: Form 8-K, filed Dec 29, 2025

- Company: [Inovio Pharmaceuticals, Inc.](/companies/ino.md) (CIK 1055726)
- Form: 8-K
- Filed: 2025-12-29
- Accepted by EDGAR: Dec 29, 2025, 08:20 ET
- Period: 2025-12-29
- Accession: 0001193125-25-332322
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1055726/000119312525332322/d78035d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1055726/000119312525332322/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1055726/000119312525332322/d78035d8k.htm

Filed Dec 29, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-332322. Last ingested by Listed: Nov 11, 2026, 00:27 ET. No prices; not investment advice.